Skip to main content
. 2023 Oct 5;148(17):1330–1339. doi: 10.1161/CIRCULATIONAHA.123.065192

Figure 4.

Figure 4.

Competing risks of death, transplant, and no event (transplant-free survival). A, Competing risk for those who received a modified Blalock-Taussig-Thomas shunt (mBTTS). B, Competing risk for those who received a right ventricle-to-pulmonary artery shunt (RVPAS).